Month: August 2019

Physna: Compare thousands of 3D models in seconds

Posted on Updated on


Physna: Compare thousands of 3D models in seconds,
According to Physna’s CEO Paul Powers and Glenn Warner, “Through revolutionary artificial intelligence, Physna uses advanced algorithms to dissect and analyze 3D objects in the blink of an eye.
Many companies have collectively spent billions of dollars on this problem. The reason that Physna is the first to actually fix it is that we used a fundamentally different type of technology.
Compare your IP with others in seconds, ensuring that you’re using the correct models and nobody else is using your designs. Promptly determine if a 3D object matches your standards, allowing you to get to market quicker. Find any 3D object in seconds, old or new, helping to keep department and operation costs to a minimum. Compare any two models instantly and see exactly how much they match with total accuracy and reliability. We call those facets. Everything in nature can be broken down into triangles. We basically analyze the relationship of facets to each other and to the surrounding environment.”


Don’t phear the phunny name: Physna could soon be a $1 billion software company

The Midwest is the opportunity of our lifetime


Physna raises $6.9 million to develop “Google of 3D models”


Prellis Biologics has raised $8.7M

Posted on Updated on

According to Dr. Alex Morgan, Principal at Khosla Ventures and Dr. Melanie Matheu, Prellis Biologics’ co-founder and CEO, “Regenerative medicine has made enormous leaps in recent decades. However, to create complete organs, we need to build higher-order structures like the vascular system. Prellis’ optical technology provides the scaffolding necessary to engineer these larger masses of tissues. With our investment in Prellis, we’re supporting an initiative that will ultimately produce a functioning lobe of the lung, or even a kidney, to be used in addressing an enormous unmet global need.

The human tissue engineering is the ability to build complex tissues with working vascular systems. The future of regenerative medicine revolves around harnessing the power of our own cells as therapeutics and building the tissues to keep them alive. Khosla Ventures is the perfect investor to support our merging of deep tech and cutting-edge regenerative medicine. With this technology in hand, we can begin to ask questions about real 3D cell biology that have never been asked before.”

PRELLIS BIOLOGICS rings without background.png building life with light

EurekAlert! Science NewsA service of the American Association for the Advancement of Science